Background Endothelial dysfunction is a key step in the initiation and progression of atherosclerosis and subsequent cardiovascular complications. We examined whether peripheral endothelial function, as assessed by fingertip reactive hyperemia-peripheral arterial tonometry (RH-PAT), can provide additional clinical value to traditional risk factors for cardiovascular diseases in predicting coronary artery disease (CAD).
Introduction
Although modification of conventional coronary risk factors and lifestyle behavior has reduced its incidence, coronary artery disease (CAD) continues to be one of the most common chronic illnesses in the USA and the developed world.
Practice guidelines recommend approaches using the Framingham Risk Score (FRS) or other similar risk prediction models [1] . Traditional risk factors overall are, however, thought to account for only 50% of CAD events, indicating the presence of unknown risk factors for atherosclerosis [2] . Endothelial dysfunction is considered a key step in the initiation and progression of atherosclerosis and cardiovascular complications. Endothelial function could be a functional expression of the overall cardiovascular risk factor burden that represents the sum of all vasculoprotective factors, and is a parameter of activity of the disease [2] . Direct invasive assessment of coronary endothelial dysfunction in terms of the vasoconstrictive response to the endotheliumdependent vasodilator acetylcholine was shown to be a strong predictor of cardiac events, but it is too invasive to use routinely [3] .
Reactive hyperemia-peripheral arterial tonometry (RH-PAT) is a noninvasive, automated, quantitative clinical test used for the evaluation of peripheral endothelial function [4] . RH-PAT, as well as brachial artery flowmediated dilation (FMD), uses reactive hyperemia after forearm occlusion as a trigger to detect endotheliumdependent vasodilation. FMD represents conduit artery vasodilation, whereas RH-PAT represents microvessel vasodilation. The main advantage of the RH-PAT technique is that the contralateral arm serves as its internal control, which can be used to correct for any systemic changes during the test, in distinction to FMD. Moreover, the RH-PAT technique is easy to use and is less operator dependent [5] . The clinical usefulness of RH-PAT has been reported in several studies. The value RH-PAT was recently shown to be related to multiple traditional risk factors [6] , as well as to mental stress [7] and sleep disordered breathing [8] , which are considered novel risk factors for cardiovascular disease. Peripheral endothelial function, as assessed by RH-PAT, identifies invasively proven coronary endothelial dysfunction [9] and ischemic heart disease [10] , and predicts future cardiovascular events [11, 12] . Thus, functional vascular response, as evaluated by RH-PAT, may serve as a surrogate marker for identifying patients with CAD. However, the clinical value of RH-PAT, in addition to the established cardiovascular risk factors, in identifying patients with advanced coronary plaques is still unclear.
This study was designed to investigate the relationship between the presence of CAD and peripheral endothelial function and to assess the value of RH-PAT, in addition to traditional risk factors, as a noninvasive tool for identifying individuals with CAD.
Methods

Study design, setting, and patients
In this prospective, observational study, consecutive patients who were referred to Mayo Clinic, Rochester, Minnesota, USA, between September 2010 and April 2012 for elective coronary angiography for chest pain evaluation or due to abnormal stress test results were included. All patients underwent RH-PAT examination followed by coronary angiography on the same day, and informed consent was obtained before initiating the study. The study protocol was approved by the Mayo Clinic institutional review board.
Reactive hyperemia-peripheral arterial tonometry
Peripheral endothelial function was assessed in the fasting state before coronary angiography using RH-PAT (Itamar Medical Ltd, Caesarea, Israel). The RH-PAT method has been previously described [6, 9, 10, [13] [14] [15] . A blood pressure cuff is placed on one upper arm, whereas the contralateral arm serves as a control. Peripheral arterial tonometry probes are placed on one finger of each hand. After a 5-min equilibration period, the blood pressure cuff is inflated to 60 mmHg above systolic pressure or 200 mmHg for 5 min, and then deflated, inducing reactive hyperemia. RH-PAT data are analyzed using a computer in an operatorindependent manner. As a measure of reactive hyperemia, the RH-PAT index (RHI) is calculated as the ratio of the average amplitude of the PAT signal over a 1-min time interval, starting 1.5 min after cuff deflation, divided by its average amplitude over a 2.5-min time period before cuff inflation (baseline) through a computer algorithm automatically normalizing for baseline signal and indexed to the contralateral arm. Previous studies have demonstrated good reproducibility of the RH-PAT data recorded by this procedure [14, 16, 17] .
Coronary angiography
Coronary angiography was performed using a standard technique with 4-7 Fr right and left catheters through a femoral or radial approach. The severity of the coronary lesions was visually determined by independent cardiologists performing the procedure, blinded to the results of RH-PAT. Fractional flow reserve measurement was performed using a standard method [18] with a 0.014 inch pressuremonitoring guidewire (Wave Wire; Volcano, Rancho Cordova, California, USA) for all lesions that had been judged equivocal by the operator at the time of coronary angiography. Clinically significant CAD was defined by the presence of a coronary lesion resulting in a luminal stenosis of at least 70% (≥50% at left main) or fractional flow reserve of up to 0.80 in one or more major coronary arteries or their major branches [19] .
Coronary risk factors and Framingham Risk Score
Risk factors were current smoking (within 1 month), hypertension (arterial blood pressure > 140/90 mmHg or antihypertensive medication use), diabetes mellitus (patient history and/or need for insulin or oral hypoglycemic agents), and the presence of a family history of cardiovascular disease in first-degree male relatives younger than 55 years or first-degree female relatives younger than 65 years. The 10-year risk for coronary heart disease was calculated using the Framingham risk scoring system. This model includes age, total and highdensity lipoprotein cholesterol levels, blood pressure, diabetes, and smoking, and was designed in the setting of a community-based cohort (Framingham, Massachusetts, USA) [20] .
Statistical analysis
We used a natural logarithmic transformation of RHI (Ln_RHI) because of its skewed distribution, and the median value of Ln_RHI (0.75846) was used to divide patients into two groups (high and low Ln_RHI). Continuous variables were presented as mean SD or median (interquartile range). Differences between continuous variables were analyzed using an unpaired t-test or the Mann-Whitney U-test, as appropriate. Categorical variables were presented as frequencies and percentages, and intergroup comparisons were analyzed using Fisher's exact test. Associations between the presence of CAD and cardiovascular risk factors were analyzed by univariate and multivariate logistic regression analyses using a forced entry method. We created two models to evaluate the additional value of Ln_RHI (Model-1: age, sex, BMI ≥ 30, current smoking, hypertension, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, and triglycerides; Model-2: FRS). Receiver operating characteristic curves were constructed for Model-1 and Model-2 and combined with Ln_RHI. The areas under the curve (C-statistics) were calculated to assess the ability to detect individuals with CAD and to detect individuals with coronary revascularization. A C-statistic value of 0.5 indicates that the model is no better than chance, whereas a value of 1.0 indicates that the model has perfect discrimination. The usual thresholds were considered: at least 0.7, good discrimination; at least 0.8, very good; and at least 0.9, excellent. Considering that the C-statistic is insensitive to further improvements in prediction once a good prediction model has been built [21] , we did not assess the difference between C-statistics. To overcome the limitations of the C-statistic, the increased discriminative value after the addition of Ln_RHI to Model-1 and Model-2 was estimated using the net reclassification index (NRI) [21] . The category-free NRI was used in this study because established a-priori risk categories do not exist [22] . Briefly, the predicted event rate of CAD or revascularization estimated using Model-1 or Model-2 alone was subtracted from the predicted event rate of CAD or revascularization estimated using Model-1 or Model-2 plus Ln_RHI for each participant. The category-free NRI statistic is calculated as the net proportion of patients for whom the risk with the expanded model is higher than the risk with the baseline model plus the net proportion of controls for whom the risk with the expanded model is lower than the risk with the baseline model. This metric does not require the specification of categories of risk and relies on the proportions of patients with events correctly assigned a higher model probability after adding the new biomarker to the model and patients without events correctly assigned a lower model probability after adding the new biomarker. Thus, NRI = 0.5 indicates that the new model improves risk prediction in 50% of all participants. A two-sided P-value of less than 0.05 was considered statistically significant. All analyses were carried using JMP version 9.0.0 (SAS Institute Inc., Cary, North Carolina, USA) and SAS 9.3 software (SAS Institute Inc.).
Results
Patients
A total of 119 patients were included initially, with one patient subsequently excluded because of a poor quality signal of RH-PAT ( Fig. 1) . Therefore, 118 patients were included in the study. After baseline evaluation, which included RH-PAT examination, coronary angiography was performed in all of the patients. Sixty (50.8%) had significant CAD (single-vessel in 36 and multivessel in 24), among whom 50 underwent coronary revascularization (34 percutaneous coronary intervention and 16 coronary artery bypass grafting). The rest underwent medical management alone. Fractional flow reserve measurements were performed in three patients, and two of these patients were diagnosed as having significant CAD according to fractional flow reserve results. The mean FRS was 12.9 9.1%, and it was significantly higher in patients with CAD than in those without CAD (15.6 9.8 vs. 10.1 7.3, P < 0.001).
The overall mean age of all patients was 62.7 11.4 years, with a male predominance (74%). Table 1 summarizes patient characteristics and concomitant medication use according to the Ln_RHI value. The group with Ln_RHI below the median had more male patients (84.8 vs. 62.7%, P = 0.01), more patients with diabetes (33.9 vs. 8.5%, P = 0.001), and more patients concomitantly using antidiabetic drugs (27.1 vs. 6.8%, P = 0.006) compared with the group with Ln_RHI above the median. Patients with lower Ln_RHI also had lower systolic blood pressure (124 14 vs. 131 17 mmHg, P = 0.02) and a higher glucose level [105 mg/dl (94-135 mg/dl) vs. 98 mg/dl (91-107 mg/dl), P = 0.01] compared with those with higher Ln_RHI. More patients in the group with lower Ln_RHI were diagnosed as having significant CAD by coronary angiography (69.5 vs. 32.2%, respectively, P < 0.001) and required coronary revascularization (52.5 vs. 32.2%, respectively, P = 0.04). Patients with CAD and those who underwent revascularization had significantly lower Ln_RHI levels (Fig. 2 ). Although the difference was not significant, multivessel disease tended to be slightly more frequently observed in the lower compared with the higher Ln_RHI group (27.1 vs. 13.6%, P = 0.11).
Factors associated with coronary artery disease
In univariate logistic regression analysis, male sex, smoking, diabetes, higher glucose levels, lower highdensity lipoprotein cholesterol levels, higher triglyceride levels, use of aspirin, higher FRS, and lower Ln_RHI were all found to be significantly associated with the presence of CAD (Table 2) . To evaluate the dependency of Ln_RHI on established cardiovascular risk factors in relation to the presence of CAD, we carried out multivariate logistic regression analyses. In both Model-1 (adjusted for traditional risk factors for cardiovascular disease) and Model-2 (adjusted for the FRS), Ln_RHI was found to be significantly associated with the presence of CAD [odds ratio for a 0.1 decrease in Ln_RHI (95% confidence interval): Model-1: 1.25 (1.04-1.52), P = 0.01; Model-2: 1.30 (1.12-1.54), P < 0.001; Table 3 ].
In multivariate logistic regression analysis, FRS and Ln_RHI showed borderline significance in identifying patients in need of coronary revascularization [odds ratio (95% confidence interval): 1 point increase in FRS: 1.04 (0.99-1.09), P = 0.056; 0.1 decrease in Ln_RHI: 1.15 (1.00-1.33), P = 0.050].
Incremental effect of adding Ln_RHI for predicting CAD
The C-statistic increased for prediction of CAD when Ln_RHI was incorporated with traditional risk factors (Model-1, from 0.80 to 0.82) and FRS (Model-2, from 0.68 to 0.75; Fig. 3 ). The NRI was significant on addition of Ln_RHI to risk factors (index, 0.26 for patients with CAD, 0.36 for patients without CAD, and 0.62 overall, P = 0.001) and FRS (index, 0.37 for patients with CAD, 0.28 for patients without CAD, and 0.64 overall, P < 0.001; Table 4 ).
We also evaluated the incremental effect of adding Ln_RHI to identify patients requiring coronary revascularization. The C-statistic increased for prediction of revascularization when Ln_RHI was incorporated into Model-1 (from 0.71 to 0.73) and FRS (from 0.62 to 0.66).
The NRI was significant with the addition of Ln_RHI to Model-1 (index, 0.23 for patients with revascularization, 0.24 for patients without revascularization, and 0.48 overall, P = 0.013) and was borderline significant when Ln_RHI was added to FRS (index, 0.20 for patients with revascularization, 0.15 for patients without revascularization, and 0.35 overall, P = 0.063; Table 4 ).
Discussion
Our current study demonstrates that patients with CAD have attenuated peripheral endothelial function, as measured by RH-PAT, compared with those without CAD. Adding Ln_RHI to the established cardiovascular risk factors and FRS significantly augments risk stratification, as evidenced by NRI, suggesting that the addition of noninvasive assessment of peripheral endothelial function could be clinically valuable for identifying patients with CAD.
Many studies have demonstrated the crucial role of endothelial dysfunction in the pathogenesis of atherosclerosis and cardiovascular diseases [23] [24] [25] [26] [27] . The RH-PAT device is Food and Drug Administration-approved for assessing peripheral endothelial function [4, 15] . The RH-PAT technique has been demonstrated to be satisfactorily reproducible [13, 14, 16, 28] , and the relations with cardiovascular risk factors [6] , coronary endothelial dysfunction [9] , and cardiovascular events [11, 12, 28] have been reported. Taken together, measurement of peripheral vasodilator response with a fingertip PAT device is potentially useful in clinical cardiovascular medicine. The Framingham Heart Study reported no statistically significant relation between RH-PAT and FMD, and concluded that these two methods have differing relations with cardiovascular risk factors [29] . Although it has been reported that nitric oxide bioavailability plays a substantial role in both these methods [30, 31] , other substances, such as prostaglandin and adenosine hydrogen peroxide, can also affect vasodilation in response to shear stress and ischemia [32] . Interestingly, although FMD with proximal placement of the occlusion cuff elicits the production of a range of vasodilators compared with FMD with distal cuff placement, which is more NO dependent, FMD with proximal occlusion is more predictive of cardiovascular events [33] . Moreover, it has been reported that microvascular function measured in terms of blood flow or shear stress response after cuff release possesses independent predictive value, and such responses are not solely NO mediated [34] [35] [36] [37] . FMD and RH-PAT might complementarily reflect distinct aspects of vascular function. This study is the first to show significant incremental value for adding noninvasive endothelial function assessment by RH-PAT to the established cardiovascular risk factors and FRS in identifying obstructive CAD among patients complaining of chest pain, as evidenced by NRI, suggesting that the assessment of endothelial function using RH-PAT can be an effective clinical tool to improve cardiovascular practice. A part of our study patients without significant CAD might have early coronary atherosclerosis or coronary spasm. As reported previously, compared with the healthy population, RH-PAT values in patients with coronary abnormalities or multiple cardiac risk factors may be impaired [9, 10, 38] ; nonetheless, the present study demonstrated a substantial predictive value of endothelial function for clinically significant obstructive CAD. Furthermore, on the basis of the current data, the relatively small number of patients, and the receiver operating characteristic analysis, it seems that practical implementation of the test is indeed possible for risk estimation based on good C-statistics (0.75-0.82), which are not very different from the predictive value of the coronary calcium score for the prediction of CAD [39, 40] . However, the exact recommended cut-off value of Ln_RHI for the identification of CAD is still unknown given the overlap in RHI values between the two groups (with and without CAD).
An obstructive plaque in a coronary artery is an anatomic marker of advanced atherosclerosis, which generally requires a prolonged time course to progress, whereas attenuation in RH-PAT is a physiological vascular disorder, which may be reversible [13, 38, 41, 42] and involved in early and all steps of atherosclerosis. Endothelial dysfunction is considered an integrated index of all atherogenic and atheroprotective factors currently present in an individual. In this study, we demonstrated the predictive value of RH-PAT, in addition to traditional risk factors, for identifying patients at high risk for obstructive CAD. Furthermore, a recent study reported that RH-PAT evaluation improved prognostic risk discrimination for future cardiovascular events when added to the FRS and coronary plaque complexity assessment in high-risk patients, including those with obstructive CAD [12] . Kitta et al. [43] showed that patients with CAD and endothelial dysfunction, as assessed by FMD, had better cardiovascular prognosis if their endothelial function improved after 6 months of optimized therapy compared with patients who had persistent impairment of their endothelial function. Hence, given its reversibility [13, 38, 41, 42] and the availability of this diagnostic tool to identify patients at risk and to control the efficacy of therapy in clinical practice, endothelial dysfunction may be an attractive primary target in the effort to optimize individualized therapeutic strategies to reduce cardiovascular morbidity and mortality.
Strengths and limitations of the study
The strength of this study is that endothelial function was prospectively assessed on the same day as coronary angiography, and the physicians performing coronary angiography were blinded to this information. Although the patients were studied prospectively and consecutively, all of the study participants underwent coronary angiography for clinically Receiver operating characteristic curves. Model-1 consists of sex, age, BMI ≥ 30, smoking, hypertension, diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, and triglycerides. AUC, area under the curve; CAD, coronary artery disease; FRS, Framingham Risk Score; Ln_RHI, natural logarithmic transformation of the reactive hyperemiaperipheral arterial tonometry index. suspected CAD. Therefore, selection bias may affect the results. Second, although withdrawal of medications would be impractical and unethical, drugs may influence endothelial function. Third, we adopted the FRS as one of the baseline models to assess the probability of atherosclerosis. However FRS has been established as a tool to calculate the risk for CAD at 10 years. Fourth, it was reported that nonobstructive CAD including coronary spastic angina, microvascular spasm, and microcirculatory insufficiency was also associated with attenuated endothelial function [10] . In this study, the acetylcholine provocation test to evaluate clinically suspected coronary spasm was performed only in two patients. Of these, one patient was diagnosed with coronary spastic angina and the peripheral endothelial function was low (Ln_RHI =0.5766). We might underestimate the prevalence of nonobstructive CAD in this study.
Conclusion
Attenuated Ln_RHI, a noninvasive marker of systemic endothelial dysfunction, successfully identified obstructive CAD, and its addition to established risk factors significantly improved risk classification for the presence of CAD. These results suggest that systemic endothelial dysfunction may reflect the presence of advanced coronary atherosclerotic plaque.
